Gilead did not put HCV drug sale in 2014 total revenue forcast# Stock
f*y
1 楼
Any one guess why? Analyst estimates the HCV drug sale is $3.5B to $5B.
Gilead total sale is $11B, but that is excluding the HCV.
So Gilead put half of their sale number off the guideline of 2014.
Gilead total sale is $11B, but that is excluding the HCV.
So Gilead put half of their sale number off the guideline of 2014.